sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Position in Mural Oncology
The Vanguard Group, Inc. has released a Form 8.3 regarding its interests in Mural Oncology plc. This disclosure follows the guidelines of the Irish Takeover Panel. As of 21 July 2025, Vanguard held 772,563 ordinary shares, accounting for 4.47% of Mural Oncology's relevant securities.
The statement also confirms a recent sale of 16 ordinary shares at a price of 2.48 USD each. No additional dealings, such as cash-settled or stock-settled derivatives, were reported. Furthermore, there are no existing indemnities or other arrangements related to these securities.
This disclosure emphasizes that Vanguard currently does not have any agreements or understandings concerning options or derivatives connected to Mural Oncology.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.